Figure 2From: Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potentialEffects of resveratrol on the surface expression of death receptors. (A, B, C and D), LNCaP cells were treated with resveratrol (0, or 10 μM) for 48 h and expressions of death receptors TRAIL-R1/DR4, TRAIL-R2/DR5, TRAIL-R3/DcR1 and TRAIL-R4/DcR2 were measured by flowcytometry.Back to article page